Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/22/2000CA2194158C Desquamation compositions
08/22/2000CA2187409C Stable crystalline tetrahydrofolic acid salts
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2165992C Disulphides
08/22/2000CA2143246C Imidazodiazepines
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/22/2000CA2085987C Piperidyl-substituted indoles
08/22/2000CA2020554C Process for the control of sea lice
08/22/2000CA2001754C Glucan dietary additives
08/17/2000WO2000047758A2 Methods of making compounds
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047734A1 Inhibiting formation of atherosclerotic lesions
08/17/2000WO2000047733A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
08/17/2000WO2000047720A2 Pancreatic progenitor cells, methods and uses related thereto
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047609A1 Cyclic peptides and aids vaccines
08/17/2000WO2000047604A1 Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047601A1 Shortened-chain polynucleotides and process for the preparation thereof
08/17/2000WO2000047599A1 Novel nucleosides and oligonucleotide analogues
08/17/2000WO2000047597A1 Avermectin derivatives
08/17/2000WO2000047596A1 Method for purifying a red fruit extract containing anthocyanosides
08/17/2000WO2000047594A1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
08/17/2000WO2000047591A1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
08/17/2000WO2000047584A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047582A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
08/17/2000WO2000047581A1 Therapeutic nucleoside compound
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047573A1 Heterocyclic derivatives as inhibitors of factor xa
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047571A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
08/17/2000WO2000047568A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000WO2000047567A1 Heterodiazinone derivatives
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047561A1 Non-nucleoside reverse transcriptase inhibitors
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047558A1 Amide compounds and medicinal use thereof
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047551A2 Inhibitors of aspartyl protease
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
08/17/2000WO2000047236A1 Matrices for drug delivery and methods for making and using the same
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047215A2 Methods for anti-tumor therapy
08/17/2000WO2000047214A1 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
08/17/2000WO2000047213A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption and method for preparing and use of same
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047211A1 Short contact treatment of psoriasis with topical retinoids
08/17/2000WO2000047210A1 Use of 4-amino pyridine for treatment of peripheral neuropathies
08/17/2000WO2000047209A1 Methods of modulating uric acid levels
08/17/2000WO2000047208A1 A transdermal composition of an antivomiting agent and a preparation containing the same
08/17/2000WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047206A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
08/17/2000WO2000047205A1 Tyrosine kinase inhibitors and methods of using the same
08/17/2000WO2000047204A1 Adp-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient
08/17/2000WO2000047203A1 Formulation and system for intra-oral delivery of pharmaceutical agents
08/17/2000WO2000047202A1 Felbamate derived compounds
08/17/2000WO2000047201A1 The pharmacological use of certain cystine derivatives
08/17/2000WO2000047200A1 Combinations of formoterol and a tiotropium salt
08/17/2000WO2000047199A1 Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases
08/17/2000WO2000047198A2 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/17/2000WO2000047197A2 Alkylating agents for treatment of cellular proliferation
08/17/2000WO2000047196A2 Use of statins for treating viral infections
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000WO2000047193A2 Inhibition of angiogenesis with epigallocatechin-3-gallate
08/17/2000WO2000047192A2 UBIQUINONE QnFOR THE TREATMENT OF PAINS
08/17/2000WO2000047191A1 Laminates containing an active substance for transdermal systems
08/17/2000WO2000047189A1 Pharmaceutical effervescent formulation containing metamizol
08/17/2000WO2000047188A1 Oxadiazole compounds and compositions for delivering active agents
08/17/2000WO2000047185A1 SPRAY CONTAINING UBIQUINONE Q¿n?
08/17/2000WO2000047184A1 Skin sanitizing compositions
08/17/2000WO2000047179A1 Skin lightening agents
08/17/2000WO2000047177A1 Use of nanoscale chitosanes and/or chitosane derivatives
08/17/2000WO2000047163A2 Use of hyaluronic acid or fragments thereof for regulating hematopoietic differentiation
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000047144A1 Prolonged release bioadhesive vaginal gel dosage form
08/17/2000WO2000047133A1 Method and composition for preventing surgical adhesions and tissue damage employing fluorinated polymers
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000047045A1 Preservative compounds and compositions
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000031273A3 Process for oxidising terpenes
08/17/2000WO2000030637A8 Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000027857A3 Novel erythromycin derivatives, preparation method and use as medicines
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000026199A3 Use of n-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives as selective mglur1 antagonists
1 ... 6260 6261 6262 6263 6264 6265 6266 6267 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 ... 7860